Home
About
- Directors and Management
- Careers
Corporate Governance
Investors
- Public Disclosure Policy
- ASX Announcements
  - 2023
  - 2022
  - 2021
  - 2020
  - 2019
  - 2018
  - 2017
  - 2016
  - 2015
  - 2014
  - 2013
  - 2012
  - 2011
  - 2010
  - 2009
  - 2008
- Financial Information & Reports
- Share Registry Information
- Analyst Coverage
- Share Information
- Anagenics in the media
- Newsletter Archive
Contact

✕

BioTech Capital

Home
BioTech Capital

November 15, 2019

Published by Tiffany McMillan on November 15, 2019

Categories

Cellmid banks research and development tax incentive

Do you like it?0

ANAGENICS LIMITED

ASX: AN1

Suite 204, Level 2
55 Clarence Street
Sydney NSW 2000
Australia

Interested in Anagenics Shares?

Find out about the range and latest price of Anagenics Limited shares

Latest ASX Announcements

21/02/2023 - Despatch of Retail Offer Booklet

21/02/2023 - Entitlement Offer – Letter to Ineligible Shareholders

17/02/2023 - Application for quotation of securities – AN1

*Anagenics was formerly Cellmid Limited (ASX:CDY)
© 2023 Anagenics Limited. All Rights Reserved. ABN 69 111 304 119. Privacy Policy